Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: The Role of Platelet TLRs in Platelet Activation During VTE
Recruitment is ongoing for a study examining how platelet Toll-like receptors contribute to platelet activation in venous thromboembolism.
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Padua Prediction Score for VTE Risk in Thoracic Surgery Patients
A clinical trial update evaluating the Padua Prediction Score for predicting the risk of deep vein thrombosis and venous thromboembolism in …
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization [Phase 4]
Phase 4 trial assessing the incidence of venous thromboembolism after rivaroxaban plus aspirin versus single antiplatelet therapy following …
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: GEKO Venous Thromboembolism Prevention Study [NA]
The GEKO Venous Thromboembolism Prevention Study is currently recruiting and investigates prevention of venous thromboembolism in the contex…
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: Low Molecular Weight hEparin vs. Aspirin Post-partum [NA]
A completed clinical trial comparing low molecular weight heparin with aspirin for postpartum prevention of venous thromboembolism.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity [Phase 3]
The PARTUM trial is a Phase 3 study evaluating postpartum aspirin to reduce venous thromboembolism. The study status is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers
This clinical trial update describes the DOCE study, which is examining potential interactions between direct oral anticoagulants and drug-m…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer [Phase 3]
A Phase 3 trial comparing long-term Innohep (tinzaparin) to Warfarin for treating venous thromboembolism in cancer patients has completed.
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Variations in the Hemostatic System Induced by a Standardized Walking Test [NA]
A recruiting clinical trial investigating how a standardized walking test alters the hemostatic system in people at risk for venous thromboe…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: AQT90 FLEX D-dimer Clinical Sensitivity and Specificity
Trial update reporting on the sensitivity and specificity of the AQT90 FLEX D-dimer assay for diagnosing venous thromboembolism.
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: PeriOperative ISchemic Evaluation-3 Trial [Phase 3]
The PeriOperative Ischemic Evaluation-3 trial, a Phase 3 study sponsored by Population Health Research Institute, has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Venous Thromboembolism During COVID-19 Pandemic: Evaluation of the Association With the Vaccine and COVID-19 Infection
This completed clinical trial assessed whether venous thromboembolism risk is linked to COVID-19 infection or vaccination.
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Recurrence of Thromboembolic Venous Disease of Atypical Location (RUSE)
This Clinical Trial Update describes the RUSE trial (NCT06815874) on recurrence of thromboembolic venous disease at atypical locations, spon…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: DVT After Cardiac Procedure
A clinical trial update reports that the study evaluating deep vein thrombosis and venous thromboembolism after a cardiac procedure has comp…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Thrombosis Outcomes in Pediatric Venous Thromboembolism
Notes that a pediatric venous thromboembolism trial evaluating thrombosis outcomes, sponsored by the University of Texas Southwestern Medica…
-
FDA approval · 2025-01-28FDA Approved: DABIGATRAN ETEXILATE — Original Application (Dr.Reddys Laboratories Inc)
FDA approved Dr.Reddys Laboratories Inc for a generic version of dabigatran etexilate under an Original Application, making the product avai…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: ThRombosis ExclUsion STudy
A terminated clinical trial sponsored by Diagnostica Stago related to venous thromboembolism has posted its results.
-
EMA approval · 2025-01-21EMA Authorised: Dabigatran etexilate Teva (previously Dabigatran etexilate Leon Farma) (dabigatran etexilate mesilate) — Teva GmbH
The EMA authorised Teva's dabigatran etexilate mesilate product for prevention of venous thromboembolism, including after arthroplasty (join…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty [Phase 2]
Phase 2 trial update for SHR-2004 evaluating prevention of venous thromboembolism in patients undergoing total knee arthroplasty; the study …
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty [Phase 3]
Phase 3 clinical trial update investigating enhanced recovery and shortened anticoagulation for thromboprophylaxis after primary total hip a…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test. [Phase 4]
Phase 4 trial evaluating individual dose adjustment of low-molecular-weight heparin by a thromodynamics test was terminated.
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Screening for Occult Malignancy in Patients with Unprovoked Venous Thromboembolism [NA]
This clinical trial aims to screen for occult malignancy in patients with unprovoked venous thromboembolism and is currently recruiting, spo…
-
FDA approval · 2024-12-10FDA Approved: HEPARIN SODIUM — Supplemental Application (Hospira, Inc.)
FDA approved Hospira's supplemental application for Heparin Sodium, updating the product's approval details.
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 [Phase 4]
Phase 4 trial evaluating intermediate or prophylactic-dose anticoagulation to prevent venous or arterial thromboembolism in adults with seve…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: The Incidence of Venous Thromboembolism in Atopic Dermatitis
This clinical trial update reports completed results on the incidence of venous thromboembolism in individuals with atopic dermatitis, with …